Skip to main content
Equibles

T. Rowe Price Investment Management, Inc.

Position in IMVT — Immunovant, Inc.

CIK 1897612 BALTIMORE, MD
Back to IMVT Full portfolio

Position in IMVT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$85,617,551
-$4,125,891 QoQ
Shares Held
2,222,101
-38.5% QoQ
Ownership
1.08%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#16
of 226 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IMVT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

T. Rowe Price Investment Management, Inc. holds $12,305,680,119 across 52 Biotechnology names. IMVT ranks #26 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ASND
Ascendis Pharma A/S
 6,754,846 $1,801,652,525
2 ALNY
Alnylam Pharmaceuticals, Inc.
 5,642,173 $1,698,463,338
3 CYTK
Cytokinetics Inc
 18,718,498 $1,594,628,844
4 KYMR
Kymera Therapeutics, Inc.
 6,257,261 $717,520,118
5 PCVX
Vaxcyte, Inc.
 12,207,450 $709,619,068
6 DYN
Dyne Therapeutics, Inc.
 30,912,287 $686,561,894
7 CGON
CG Oncology, Inc.
 6,616,899 $470,130,673
8 IMNM
Immunome Inc.
 19,676,883 $416,953,150

All Filings in IMVT

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $85,617,551 2,222,101
2026-03-31 $89,743,442 3,612,860
2025-12-31 $14,577,429 573,463
2025-09-30 $83,254,931 5,164,698
2025-06-30 $110,063,296 6,878,956
2025-03-31 $100,742,542 5,894,824
2024-12-31 $126,753,886 5,117,234
2024-09-30 $94,967,294 3,331,017
2024-06-30 $42,905,808 1,625,220